WAVEMAN · COMPANY

CTTH · Ctt Pharmaceutical Holdings, Inc.

LIVE

TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475

← ALL COMPANIES

CTTH

Name: CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

CTT PHARMACEUTICAL HOLDINGS, INC.

PHARMA & BIOTECH · PHARMACEUTICAL PREPARATIONS · CIK 0001035422

C-SUITE BUYING · 1☆ WATCH

INSIDER NET · 180D

$2.6K

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

XBRL, annual

NET MARGIN

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net +$2.6K over 180 days

+$2.6K over 90 days

more than 65% of Pharma & Biotech

CONGRESS

no member of Congress has reported trading it

FUNDS

fewer than five institutions report holding it

REVENUE

no revenue reported in any filing

MARGIN

no margin: this company reports no revenue to divide by

BUYBACKS

no share repurchases reported

SHORT

1.0 days to cover · settled 2026-07-31

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN -10.9%

-10.9%12M

INSIDER BUY

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

Insiders are net buyers of their own stock.

The record shows a net $2.6K bought by insiders over 180 days. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

UTHR CPIX MRNA REGN LLY ALNY ELF CITR MDGL DNA VRTX NUVL

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, CTT PHARMACEUTICAL HOLDINGS, INC. insiders bought a net $2.6K of stock across 56 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER

FILED

VALUE

CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

BUY

2026-09-04

9,800.0

$479

CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

BUY

2026-09-02

3,000.0

$147

CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

BUY

2026-08-31

3,500.0

$172

CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

BUY

2026-08-24

2,100.0

$116

CTT PHARMACEUTICAL HOLDINGS, INC.

CEO

BUY

2026-08-20

11,500.0

$518

56 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 51 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

no 13F holders found for this ticker

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.